These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 18000488)

  • 61. Correlations of attitudes toward antipsychotic drugs with insight and objective psychopathology in schizophrenia.
    Rocca P; Crivelli B; Marino F; Mongini T; Portaleone F; Bogetto F
    Compr Psychiatry; 2008; 49(2):170-6. PubMed ID: 18243890
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Cognitive deficits in schizophrenia and other psychotic disorders].
    Fagerlund B; Glenthøj BY
    Ugeskr Laeger; 2008 Nov; 170(46):3770-2. PubMed ID: 19014728
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Schizoaffective disorder: clinical aspects, differential diagnosis, and treatment.
    Marneros A
    Curr Psychiatry Rep; 2003 Jul; 5(3):202-5. PubMed ID: 12773273
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Electroencephalographic findings in relation to diagnostic constructs in psychiatry.
    Small JG; Milstein V; Sharpley PH; Klapper M; Small IF
    Biol Psychiatry; 1984 Apr; 19(4):471-87. PubMed ID: 6733170
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antipsychotics side effects' influence on stigma of mental illness: focus group study results.
    Novak L; Svab V
    Psychiatr Danub; 2009 Mar; 21(1):99-102. PubMed ID: 19270631
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Psychopathology of schizophrenia and brain imaging].
    Gross G; Huber G
    Fortschr Neurol Psychiatr; 2008 May; 76 Suppl 1():S49-56. PubMed ID: 18461545
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Munich 15-year follow-up study (MUFUSSAD) on first-hospitalized patients with schizophrenic or affective disorders: assessing courses, types and time stability of diagnostic classification.
    Möller HJ; Jäger M; Riedel M; Obermeier M; Strauss A; Bottlender R
    Eur Psychiatry; 2011 May; 26(4):231-43. PubMed ID: 20621452
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Synthetic delta-9-tetrahydrocannabinol (dronabinol) can improve the symptoms of schizophrenia.
    Schwarcz G; Karajgi B; McCarthy R
    J Clin Psychopharmacol; 2009 Jun; 29(3):255-8. PubMed ID: 19440079
    [TBL] [Abstract][Full Text] [Related]  

  • 69. 'Salience syndrome' replaces 'schizophrenia' in DSM-V and ICD-11: psychiatry's evidence-based entry into the 21st century?
    van Os J
    Acta Psychiatr Scand; 2009 Nov; 120(5):363-72. PubMed ID: 19807717
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Compliance with treatment in schizophrenia and mood disorders].
    Sorvaniemi M; Kampman O
    Duodecim; 2000; 116(3):277-84. PubMed ID: 11764451
    [No Abstract]   [Full Text] [Related]  

  • 71. Long-term clinical course of patients with acute polymorphic psychotic disorder without symptoms of schizophrenia.
    Abe T; Otsuka K; Kato S
    Psychiatry Clin Neurosci; 2006 Aug; 60(4):452-7. PubMed ID: 16884447
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Use of Hunperdal Richter in psychiatry].
    Magyar GI; Fadgyas I
    Neuropsychopharmacol Hung; 2009 Jun; 11(2):111-5. PubMed ID: 19827319
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Generic quetiapine in the treatment of acute schizophrenia and schizoaffective disorder].
    György B; Robert K; László C; Andrea J;
    Neuropsychopharmacol Hung; 2008 Dec; 10(5):293-303. PubMed ID: 19419015
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Psychotropic medication use in people with developmental disabilities.
    Curtis JL
    Md Med J; 1997 Oct; 46(9):481-5. PubMed ID: 9327650
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Differential diagnosis and diagnostic systems in schizophrenia.
    Doran AR; Breier A; Roy A
    Psychiatr Clin North Am; 1986 Mar; 9(1):17-33. PubMed ID: 3515329
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Conceptualizing ADHD.
    Bellak L; Opler LA
    J Clin Psychiatry; 1994 Jul; 55(7):312-3. PubMed ID: 7915276
    [No Abstract]   [Full Text] [Related]  

  • 77. High-dose ziprasidone in treatment-resistant schizophrenia and affective spectrum disorders: a case series.
    Deutschman DA; Deutschman DH
    J Clin Psychopharmacol; 2007 Oct; 27(5):513-4. PubMed ID: 17873687
    [No Abstract]   [Full Text] [Related]  

  • 78. Switching antipsychotic medications: a 2-year chart-review study exploring patient characteristics and psychiatric service use of schizophrenia patients.
    Schneider AL; Mosier KE; Tempier RP
    J Clin Psychiatry; 2009 Jun; 70(6):937-9. PubMed ID: 19573492
    [No Abstract]   [Full Text] [Related]  

  • 79. [The Schreber case and Freudian dynamic psychopathology of psychoses].
    Matsumoto T; Kato S
    Seishin Shinkeigaku Zasshi; 2009; 111(9):1021-40. PubMed ID: 19999560
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Posttraumatic stress disorder, cognitive function and quality of life in patients with schizophrenia.
    Fan X; Henderson DC; Nguyen DD; Cather C; Freudenreich O; Evins AE; Borba CP; Goff DC
    Psychiatry Res; 2008 May; 159(1-2):140-6. PubMed ID: 18423611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.